Beachbum3232 Tuesday, 07/21/20 09:35:58 PM Re: Amatuer17 post# 96722 Post # of 170689 I'm wondering in the case of Covid trial if it's more important to establish safety first given all the underlying health problems maybe attributed to the enrolled patients even if they are mild/moderate, you know the doctor's oath of first do no harm so to speak. And if that's the case and the safety data could be retrieved sooner than the efficacy data, then why not tout it. I think there should have been more of "heads up" that this would be the case; I think we were led to believe top line results meant safety/efficacy and everything else. We also have a passionate CEO who is focused on saving lives vs. share price ---right now. That could change but I have heard him say in the past that sometimes saving lives is more important than share price----I'm paraphrasing and obviously it's not a popular position to have when you have many investors who have been waiting for this. Folks I want this just as bad as anyone but clinical trials require patience I've worked in the industry for over 20 years and the one thing you can't rush is clinical trial results. Just my opinion.